OMOP Concept 37557435
Enfortumab vedotin and Pembrolizumab
StandardRegimenHemOnc120168Regimen
Maps from
0
Descendants
0
Valid from
19 Aug 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(28)Roll up to these when you need a wider cohort.
- 1Antibody-drug conjugate-containing regimen
- 1Antibody-drug conjugate therapy
- 1Anti-nectin-4 antibody-drug conjugate-containing regimen
- 1Anti-PD-1 antibody-containing regimen
- 1enfortumab
- 1Enfortumab vedotin-containing regimen
- 1ICI-containing regimen
- 1Immunotherapy
- 1Immunotherapy-containing regimen
- 1Multiagent regimen
- 1pembrolizumab
- 1Pembrolizumab-containing regimen
- 2Anti-nectin-4 antibody-drug conjugate
- 2Anti-PD-1 antibody
- 2Generic class-based regimen
- 2Microtubule inhibitor
- 2Named class-based regimen
- 2WHO Essential Cancer Medicine
- 3Antibody-drug conjugate
- 3Anti-nectin-4 antibody
- 3Cytotoxic chemotherapeutic
- 3Immunostimulatory monoclonal antibody
- 3WHO Essential Medicine
- 4Antibody medication
- 4Antineoplastic monoclonal antibody
Get this concept via the API
Resolve Enfortumab vedotin and Pembrolizumab - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/37557435?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card